Featured

Natalie Yeadon

Top 10 Tips for Running a Successful Virtual Event

The ways that pharmaceutical and scientific communities attend meetings and events completely changed in 2020. Virtual events are rapidly improving, as are the platforms...

Natalie Yeadon - March 25, 2021

Natalie Yeadon

The Zeigarnik Effect – What is it and how can it help increase productivity?

As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the cause of about 40-45% of...

Natalie Yeadon - January 7, 2020

Recent Articles

Over One-Third of Americans Are Not Taking Prescribed Medication Due to Financial Difficulties

Editor´s Pick February 7, 2023

Data CRO Adds New Executive Leadership to Support Expansion and Growth

Look Who’s On the Move! February 7, 2023

Allosteric Bioscience Appoints Dr. Susan Michaelis to Scientific Advisory Board

Look Who’s On the Move! February 7, 2023

US FDA Approves Takhzyro® (Lanadelumab-flyo) for the Prevention of Hereditary Angioedema (HAE) Attacks in Children Aged 2 and Above by Takeda Pharmaceuticals

Regulatory Affairs February 7, 2023

Newel Health Receives $2.5M Grant from The Michael J. Fox Foundation to Advance Soturi, a Digital Therapeutic for Parkinson’s Disease.

Editor´s Pick February 7, 2023

Zymergen to Purchase Trials.ai, an AI-Powered Clinical Trial Design Firm

Industry News February 6, 2023

Verastem Oncology Details 2023 Strategic Priorities and Upcoming Catalysts for Avutometinib as a Treatment for RAS Pathway-Driven Cancers

Industry News February 2, 2023

Arrowhead Pharmaceuticals Begins Clinical Trial of ARO-MMP7 for Idiopathic Pulmonary Fibrosis Treatment.

Industry News February 2, 2023

Exscientia and Bristol Myers Squibb Launch First Human Clinical Trial of EXS4318, a PKC Theta Inhibitor.

Industry News February 2, 2023

Clinical Review of Peginterferon Alfa-2b Suggests Amended Dosing Schedule May Improve Clinical Outcomes in Polycythemia Vera.

Industry News February 2, 2023

Guardant Health and AnHeart Therapeutics Partner to Develop Diagnostic Tests for Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer Patients Treated with Taletrectinib.

Industry News February 2, 2023

Greenleaf Health Appoints Sandra Kweder, M.D. and Donald D. Ashley, J.D. as Senior Advisors, Both Formerly of the FDA

Look Who’s On the Move! February 2, 2023

FDA Grants Clearance for RefleXion’s SCINTIX Biology-Guided Radiotherapy to Treat Early and Late-stage Cancers

Look Who’s On the Move! February 2, 2023

Onco360 Now Offers ORSERDU™ for Advanced or Metastatic ER-positive, HER2-negative, ESR1-mutated Breast Cancer in Postmenopausal Women and Adult Men Who Have Experienced Disease Progression...

Industry News February 2, 2023

Alberta Health Services Approves First Clinical Site for Study of Psychedelic-Assisted Treatment for Alcohol Use Disorder

Industry News February 2, 2023

Get a free copy of "Cracking the Generics Code"

Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.